- Home
- TNGX vs THFF Comparison
TNGX vs THFF Comparison
Compare TNGX & THFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- THFF
- Stock Information
- Founded
- TNGX 2014
- THFF 1984
- Country
- TNGX United States
- THFF United States
- Employees
- TNGX N/A
- THFF N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- THFF Major Banks
- Sector
- TNGX Health Care
- THFF Finance
- Exchange
- TNGX Nasdaq
- THFF Nasdaq
- Market Cap
- TNGX 723.0M
- THFF 625.8M
- IPO Year
- TNGX N/A
- THFF N/A
- Fundamental
- Price
- TNGX $6.53
- THFF $52.44
- Analyst Decision
- TNGX Strong Buy
- THFF Buy
- Analyst Count
- TNGX 5
- THFF 3
- Target Price
- TNGX $10.50
- THFF $59.50
- AVG Volume (30 Days)
- TNGX 1.9M
- THFF 54.5K
- Earning Date
- TNGX 08-05-2025
- THFF 07-22-2025
- Dividend Yield
- TNGX N/A
- THFF 3.89%
- EPS Growth
- TNGX N/A
- THFF 21.43
- EPS
- TNGX N/A
- THFF 5.24
- Revenue
- TNGX $40,990,000.00
- THFF $230,446,000.00
- Revenue This Year
- TNGX N/A
- THFF $30.73
- Revenue Next Year
- TNGX N/A
- THFF $2.82
- P/E Ratio
- TNGX N/A
- THFF $10.01
- Revenue Growth
- TNGX 10.09
- THFF 19.59
- 52 Week Low
- TNGX $1.03
- THFF $38.87
- 52 Week High
- TNGX $12.02
- THFF $57.91
- Technical
- Relative Strength Index (RSI)
- TNGX 60.33
- THFF 37.75
- Support Level
- TNGX $6.36
- THFF $54.73
- Resistance Level
- TNGX $7.11
- THFF $56.18
- Average True Range (ATR)
- TNGX 0.52
- THFF 1.38
- MACD
- TNGX -0.13
- THFF -0.54
- Stochastic Oscillator
- TNGX 53.15
- THFF 9.28
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About THFF First Financial Corporation Indiana
First Financial Corp operates as a financial holding company, which is engaged in the provision of financial services in the United States. The company offers a wide variety of financial services including commercial, mortgage, and consumer lending, lease financing, trust account services, depositor services and insurance services, through its subsidiaries. Its primary source of revenue is derived from loans to customers and investment activities.